| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities - continuing operations | 8,161,458 | 8,278,769 |
| Net cash provided by (used in) financing activities | 8,161,458 | 8,278,769 |
| Net increase (decrease) in cash | 2,360,295 | 3,611,530 |
| Cash and cash equivalents at beginning of period | 3,709,971 | - |
| Cash and cash equivalents at end of period | 6,070,266 | - |
Petros Pharmaceuticals, Inc. (PTPI)
Petros Pharmaceuticals, Inc. (PTPI)